BCCIP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.728000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.886800E-01
Normal-vs-Stage2
5.099000E-01
Normal-vs-Stage3
7.365200E-01
Normal-vs-Stage4
1.470770E-01
Stage1-vs-Stage2
6.948200E-01
Stage1-vs-Stage3
7.426800E-01
Stage1-vs-Stage4
5.997000E-01
Stage2-vs-Stage3
8.306800E-01
Stage2-vs-Stage4
2.698000E-01
Stage3-vs-Stage4
4.215800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.935200E-01
Normal-vs-AfricanAmerican
4.226800E-01
Normal-vs-Asian
1.316040E-01
Caucasian-vs-AfricanAmerican
8.379400E-01
Caucasian-vs-Asian
5.341200E-01
AfricanAmerican-vs-Asian
9.427800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.955400E-01
Normal-vs-Female
4.438600E-01
Male-vs-Female
7.531200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.209000E-01
Normal-vs-Age(41-60Yrs)
3.108800E-01
Normal-vs-Age(61-80Yrs)
6.104000E-01
Normal-vs-Age(81-100Yrs)
1.450150E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.707600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.342600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.070000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.441900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.903800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.489990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.609000E-01
Normal-vs-Daily Drinker
4.739400E-01
Normal-vs-Weekly Drinker
5.031600E-01
Normal-vs-Occasional Drinker
2.263000E-01
Normal-vs-Social Drinker
7.190200E-01
Non Drinker-vs-Daily Drinker
9.890800E-01
Non Drinker-vs-Weekly Drinker
9.091600E-01
Non Drinker-vs-Occasional Drinker
2.548600E-01
Non Drinker-vs-Social Drinker
4.899800E-01
Daily Drinker-vs-Weekly Drinker
8.881400E-01
Daily Drinker-vs-Occasional Drinker
2.324400E-01
Daily Drinker-vs-Social Drinker
4.271400E-01
Weekly Drinker-vs-Occasional Drinker
2.325000E-01
Weekly Drinker-vs-Social Drinker
5.375200E-01
Occasional Drinker-vs-Social Drinker
6.936300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.890000E-01
Normal-vs-Grade 2
5.819800E-01
Normal-vs-Grade 3
1.515180E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.786400E-01
Grade 1-vs-Grade 3
2.176000E-01
Grade 1-vs-Grade 4
3.890000E-01
Grade 2-vs-Grade 3
5.196400E-01
Grade 2-vs-Grade 4
5.819800E-01
Grade 3-vs-Grade 4
1.515180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.345000E-01
Normal-vs-NonDiabetic
4.886400E-01
Diabetic-vs-NonDiabetic
7.597200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.909200E-01
Normal-vs-NoPancreatitis
5.063400E-01
Pancreatitis-vs-NoPancreatitis
7.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.102000E-01
Normal-vs-N1
5.175400E-01
N0-vs-N1
3.965200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.641380E-01
Normal-vs-TP53-NonMutant
1.671610E-01
TP53-Mutant-vs-TP53-NonMutant
3.049600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
